Clinical Trial

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

Name: Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease — clinical trial record (NCT07415018)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To learn if gadopiclenol (a contrast agent) used during MRI scanning can help in the detection of early LMD.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-19

Trial Details

NCT Number	NCT07415018
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Leptomeningeal Disease
Enrollment	40 participants
Start Date	2026-06-10
Primary Completion	2027-07-31 (estimated)
Study Completion	2029-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-18